Vectura risks university research block after Philip Morris takeover

1 August 2021

Source: The Telegraph

Future partnerships with academic institutions are in jeopardy due to policies that prohibit funding being accepted from tobacco firms Vectura, the lung drug developer, risks being blocked from university research tie-ups following a £927m takeover by the world’s biggest tobacco seller. The swoop by Marlboro cigarettes maker Philip Morris for Vectura…  Read full story


Sign up to receive our monthly newsletter for the latest news and updates on our work in the ASEAN region and beyond.